title: [Vasoplegic shock and myocardial infarction during administration of iloprost].
abstract: BACKGROUND
  The association of vasoplegic shock and myocardial infarction in a patient under iloprost treatment for critical ischemia of the lower limbs has not previously been reported.
  
  
  METHODS
  A 56 year-old man suffering from type 2 diabetes, hypertension and dyslipidemia developed critical ischemia of the right leg and was treated with iloprost. On the 19th day of infusion, he developed a vasoplegic shock with myocardial infarction. The shock resolved and he recovered from the infarction.
  
  
  CONCLUSIONS
  This case report indicates the need for reinforced blood pressure and electrocardiographic monitoring in diabetes patients treated with iloprost.
authors.affiliation: Service de pathologie cardiovasculaire et de médecine aéronautique, HIA Percy, Clamart. aerocard@claranet.fr
authors.forename: E
authors.initials: E
authors.lastname: Perrier
authors.forename: G
authors.initials: G
authors.lastname: Quiniou
authors.forename: C
authors.initials: C
authors.lastname: Godreuil
authors.forename: S
authors.initials: S
authors.lastname: Geffroy
authors.forename: E
authors.initials: E
authors.lastname: Naoum
authors.forename: R
authors.initials: R
authors.lastname: Carlioz
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D005500:Follow-Up Studies; D006801:Humans; D016285:Iloprost / Q000008:administration & dosage / Q000009:adverse effects*; D007511:Ischemia / Q000188:drug therapy*; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000139:chemically induced*; D012770:Shock, Cardiogenic / Q000139:chemically induced*; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D014665:Vasodilator Agents; D016285:Iloprost